netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
09.05.02.02  Expand sub section  Phosphate-binding agents
Sevelamer Hydrochloride  (Renagel®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Shared Care Protocol
High Cost Medicine

For second line use (a calcium based binding agent is used first line) in line with Shared Care Protocol.

APCO January 2012.

 
   
Sevelamer Carbonate 2.4g sachets (Renvela®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Shared Care Protocol
High Cost Medicine

Only in patients unable to tolerate Renagel tablets (sevelamer hydrochloride).

See Shared Care Protocol for sevelamer hydrochloride.

 
   
Aluminium Hydroxide (Alu-Cap®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

For use by Renal patients only. 

Suitable for prescribing in primary care following specialist recommendation.

 
   
Calcium Acetate (Phosex®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

Suitable for prescribing in primary care following specialist recommendation.

 
   
Calcium Acetate (Renacet®)
Formulary
Amber Continuation

Addition to formulary in addition to Phosex. Phosex supply difficulties due to limitation of suppliers to pharmacies.

APCO September 2018. 

 
   
Calcium Carbonate (Calcichew®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

Suitable for prescribing in primary care following specialist recommendation.

 
   
Lanthanum (Fosrenol®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Shared Care Protocol
High Cost Medicine

Second-line to sevelamer for the control of hyperphosphataemia in patients with chronic kidney disease stage 5 who cannot tolerate calcium based phosphate binders or have pre-existing hypercalcaemia.

See Shared Care Protocol.

APCO January 2012.


 
   
 ....
 Non Formulary Items
Calcium acetate  (PhosLo®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Discontinued in 2015

 
Calcium Salts  (Calcium-500®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Calcium Salts  (Everose®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Calcium Salts  (Osvaren®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colestilan  (BindRen®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
Ferric citrate coordination complex  (Fexeric®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sucroferric Oxyhydroxide  (Velphoro®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary